ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Events

NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ

$34.74

$+0.57

(+1.66%)

NewAmsterdam Pharma Company N.V. (NAMS) Live Price Chart

Page last updated: 2026-02-12 15:52:00

Key Market Data

Market Cap	$3.94B
Open	$34.26
High	$42.00
Low	$5.63
Previous Close	$34.24
Price Change	$+0.57
Percentage Change	+1.66%
Volume	37K

NewAmsterdam Pharma Company N.V. (NAMS) Stock Price Today

NewAmsterdam Pharma Company N.V. (NAMS) is currently trading at $34.74 as of 2026-02-12 15:52:00, reflecting a +1.66% move ($+0.57) from the previous close.

In the short term, the stock has returned +882.52% over the past four weeks. Over the last 12 months, NewAmsterdam Pharma Company N.V. has recorded a +79.33% price change, indicating a strong performance relative to the broader market.

NewAmsterdam Pharma Company N.V. (NAMS) 7-Day Stock Price Changes

Over the past seven days, NewAmsterdam Pharma Company N.V. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $32.78 to the latest recorded price of $34.74, reflecting an intraday change of +1.66%. Daily movements highlight shifts in trading volume (37,422), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, NAMS has delivered a +882.52% return over the past month and a +79.33% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy NewAmsterdam Pharma Company N.V. (NAMS)

You can buy and trade NAMS on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for NAMS and Execute Your Trade

Open the trading page, enter NAMS in the search bar, select the amount of NAMS you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is NewAmsterdam Pharma Company N.V. (NAMS)?

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

NewAmsterdam Pharma Company N.V. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	77
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.newamsterdampharma.com

Frequently Asked Questions (FAQ)

1.What is the current share price of NewAmsterdam Pharma Company N.V.?

The latest trading price for NewAmsterdam Pharma Company N.V. (Common Stock) is $ 34.74, compared with a previous closing price of $ 34.24. That means the stock has moved +1.66% so far today. Intraday price updates and recent trading activity for NAMS can be tracked on the live chart and quote section on this page.

2.Is NewAmsterdam Pharma Company N.V. stock going up or down?

Looking at recent performances, NAMS has returned +882.52% over the past month, +36.76% over the last six months and +79.33% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for NewAmsterdam Pharma Company N.V. stock, but keep in mind that past returns do not guarantee future results.

3.Where does NAMS currently sit relative to its 52-week high and low?

In the most recent 52-week period, NewAmsterdam Pharma Company N.V. has traded between a low of $ 14.06 and a high of $ 42.00. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether NAMS is currently nearer the top or the bottom of its one-year trading band.

4.How is NewAmsterdam Pharma Company N.V. classified by sector and industry?

NewAmsterdam Pharma Company N.V. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means NewAmsterdam Pharma Company N.V. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing NAMS’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence NewAmsterdam Pharma Company N.V.’s performance.

5.Where is NewAmsterdam Pharma Company N.V. listed and how large is it by market value?

NewAmsterdam Pharma Company N.V. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 3.94B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of NewAmsterdam Pharma Company N.V.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does NAMS's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1.95 summarises how much profit NewAmsterdam Pharma Company N.V. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track NewAmsterdam Pharma Company N.V.'s financial performance over time?

To follow NewAmsterdam Pharma Company N.V.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how NAMS is performing and how the market is responding.

8.When is NewAmsterdam Pharma Company N.V. expected to report earnings?

NewAmsterdam Pharma Company N.V.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for NAMS, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in NewAmsterdam Pharma Company N.V.'s earnings reports?

NewAmsterdam Pharma Company N.V.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether NAMS is meeting, beating or missing expectations.

10.How can I stay informed about NewAmsterdam Pharma Company N.V.'s results and guidance?

You can stay up to date on NewAmsterdam Pharma Company N.V. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for NAMS on this page helps you see how new information is being reflected in the stock.

11.Does NewAmsterdam Pharma Company N.V. pay a regular cash dividend to its shareholders?

NewAmsterdam Pharma Company N.V. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor NAMS's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for NAMS?

Based on the latest earnings data, NAMS has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether NewAmsterdam Pharma Company N.V. is an attractive income stock. The dividend payout ratio measures what percentage of earnings NewAmsterdam Pharma Company N.V. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is NewAmsterdam Pharma Company N.V.?

NewAmsterdam Pharma Company N.V. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is NAMS valued in terms of P/E ratio and EPS?

NewAmsterdam Pharma Company N.V. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1.95. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of NewAmsterdam Pharma Company N.V.'s earnings. Comparing NAMS's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as NewAmsterdam Pharma Company N.V.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

CNA Financial Corporation

CNA

Capri Holdings Limited

CPRI

Cooper-Standard Automotive Inc.

CPS

Circle Internet Group, Inc.

CRCL

Danaos Corporation

DAC

Top Gainers

Browse today's leading gainers in the US stock market

Haoxin Holdings Limited

HXHX

Jiuzi Holdings, Inc.

JZXN

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

NAMS-to-USD Calculator

Amount

NAMS

USD

1 NAMS = 34.737 USD